These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 615753)

  • 1. [Inducibility of 1-step and multi-step resistance in Staphylococcus aureus strains].
    Cusumano V; Focà A; Zamboni C
    G Ital Chemioter; 1977; 24(1-2):113-6. PubMed ID: 615753
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of evidence for mutation to erythromycin resistance in clinical strains of Staphylococcus aureus.
    Lacey RW
    J Clin Pathol; 1977 Jul; 30(7):602-5. PubMed ID: 886013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive erythromycin resistance plasmid in Staphylococcus aureus.
    Bastos MC; Bonaldo MC; Penido EG
    J Gen Microbiol; 1980 Dec; 121(2):513-6. PubMed ID: 7264605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental research on microbiological profile of josamycin. II: Findings on the phenomenon of resistance in comparison with other macrolides].
    Maury F; Moiraghi Ruggenini A; Grassi R
    G Batteriol Virol Immunol; 1981; 74(7-12):239-49. PubMed ID: 7347696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of Staphylococcus aureus to lincomycin, clinimycin, and erythromycin.
    McGehee RF R; Barre FF; Finland M
    Antimicrob Agents Chemother (Bethesda); 1968; 8():392-7. PubMed ID: 5735385
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sensitivity of hospital strains of Staphylococcus aureus to lincomycin and clindamycin].
    Jakubicz P; Dzierzanowska D
    Pol Tyg Lek; 1980 Feb; 35(8):269-71. PubMed ID: 7360703
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness of lincomycin against Staphylococcus aureus].
    Naumann G
    Zahn Mund Kieferheilkd Zentralbl; 1986; 74(4):337-41. PubMed ID: 2944315
    [No Abstract]   [Full Text] [Related]  

  • 8. [In-vitro activity of clindamycin and lincomycin in the presence of Staphylococcus aureus].
    Wiedemann B
    Fortschr Med; 1984 Jun; 102(21):603-4. PubMed ID: 6469163
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of erythromycin plus lincomycin association on renal staphylococcia in mice induced by "dissociated resistant" Staphylococcus aureus].
    Bourse R; Daver J; Monnier J
    Ann Inst Pasteur (Paris); 1969 Jun; 116(6):750-9. PubMed ID: 5363514
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of erythromycin resistance in Staphyloccus aureus by erythromycin derivatives.
    Pestka S; Vince R; LeMahieu R; Weiss F; Fern L; Unowsky J
    Antimicrob Agents Chemother; 1976 Jan; 9(1):128-30. PubMed ID: 1259386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance in Staphylococcus aureus. Induction of macrolide resistance by erythromycin, oleandomycin and their derivatives.
    Ono H; Inoue M; Mao JC; Mitsuhashi S
    Jpn J Microbiol; 1975 Oct; 19(5):343-7. PubMed ID: 1223337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of staphylococci from farm animals to antibacterial agents used for growth promotion and therapy. A ten year study.
    Devriese LA
    Ann Rech Vet; 1980; 11(4):399-408. PubMed ID: 7337397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of lincomycin resistance by staphylococci.
    Duncan IB
    Antimicrob Agents Chemother (Bethesda); 1967; 7():723-9. PubMed ID: 5596212
    [No Abstract]   [Full Text] [Related]  

  • 14. [Loss of erythromycin sensitivity in strains of Staphylococcus aureus].
    López-Yeste ML; Lite Lite J
    Enferm Infecc Microbiol Clin; 1997 May; 15(5):280. PubMed ID: 9376396
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythromycin-resistant Staphylococcus aureus in Denmark.
    Westh H
    APMIS Suppl; 1996; 57():1-37. PubMed ID: 8600946
    [No Abstract]   [Full Text] [Related]  

  • 16. [In vitro evaluation of susceptibility to selected antibiotics of strains of staphylococcus aureus isolated from purulent skin changes].
    Jasińska B; Miturska R; Kadziela-Wypyska G; Toruń B
    Med Dosw Mikrobiol; 1994; 46(3):145-9. PubMed ID: 7996931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role of lincomycin-therapy in the genetic alteration of a staphylococcus epidemic population.
    Barcs I; Dobronyi I
    Acta Microbiol Hung; 1984; 31(3):173-8. PubMed ID: 6516785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lincomycin].
    Hye-Knudsen P
    Ugeskr Laeger; 1969 May; 131(22):962-5. PubMed ID: 5793630
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the capacity of chromosomal genes of erythromycin resistance for translocation in hospital strains of Staphylococcus aureus].
    Młynarczyk G; Młynarczyk A; Sawicka-Grzelak A; Osowiecki H
    Med Dosw Mikrobiol; 1988; 40(4):181-6. PubMed ID: 3246921
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the efficacy of josamycin in the treatment of impetigo in children and its in vitro activity on erythromycin resistant Staphylococcus aureus strains.
    Mosca A; Del Prete R; Mazzotta F; Bonifazi E; Miragliotta G
    J Chemother; 1995 Nov; 7 Suppl 4():158-9. PubMed ID: 8904141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.